Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teneligliptin in elderly patients with type 2 diabetes (TEDDY)
NCT03508323Phase 4Completed
- Sponsor
- Handok
- Start
- Apr 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of teneligliptin in type 2 diabetes mellitus (T2DM), sponsored by Handok. Started Apr 2018; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03508323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03508323.